Advertisement
News
Advertisement

Pharmalucence gets FDA approval for melanoma test

Fri, 08/17/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

In the midst of building its new facility in Billerica, Pharmalucence Inc. has received FDA approval to expand the allowed uses of its sulfur colloid injection (SCI) to include localization of lymph nodes in malignant melanoma patients.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading